Harvard Bioscience, Inc. HBIO
9.08 USD +0.72 (+8.61%)
Nov 9, 2026, 3:11 PM EST
8.35 Day range 9.32
4.00 52-week range 9.32
- YTD
- +35.52%
- 1 year
- +68.15%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 86.55M | 94.14M | 112.25M | 113.33M | 118.90M | |
| 49.91M | 54.77M | 66.07M | 60.82M | 67.65M | |
| -48.58M | -6.21M | 1.89M | -6.93M | 2.07M | |
| -56.70M | -12.40M | -3.42M | -9.52M | -288.00K | |
| -12.80 | -2.80 | -0.80 | -2.30 | -0.10 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 8.61M | 4.11M | 4.28M | 4.51M | 7.82M | |
| 80.07M | 126.64M | 137.37M | 145.36M | 162.34M | |
| 66.34M | 63.30M | 64.29M | 73.14M | 78.94M | |
| 42.75M | 43.34M | 41.36M | 54.24M | 56.96M | |
| 13.73M | 63.34M | 73.07M | 72.22M | 83.40M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 6.73M | 1.44M | 14.03M | 1.15M | 1.26M | |
| -1.86M | -1.34M | -1.80M | -1.59M | -1.34M | |
| -1.29M | -131.00K | -12.13M | -2.84M | -252.00K | |
| -1.86M | -3.26M | -2.31M | -1.59M | -1.20M | |
| 4.51M | -175.00K | -225.00K | -3.31M | -496.00K |